Presentation is loading. Please wait.

Presentation is loading. Please wait.

Morphine-Methadone Opioid Rotation in Cancer Patients: Analysis of Dose Ratio Predicting Factors  Miguel Angel Benítez-Rosario, MD, PhD, Antonio Salinas-Martín,

Similar presentations


Presentation on theme: "Morphine-Methadone Opioid Rotation in Cancer Patients: Analysis of Dose Ratio Predicting Factors  Miguel Angel Benítez-Rosario, MD, PhD, Antonio Salinas-Martín,"— Presentation transcript:

1 Morphine-Methadone Opioid Rotation in Cancer Patients: Analysis of Dose Ratio Predicting Factors 
Miguel Angel Benítez-Rosario, MD, PhD, Antonio Salinas-Martín, MD, Armando Aguirre-Jaime, MSc, Lina Pérez-Méndez, MD, PhD, Manuel Feria, DSc, PhD  Journal of Pain and Symptom Management  Volume 37, Issue 6, Pages (June 2009) DOI: /j.jpainsymman Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

2 Fig. 1 Correlation between MMEDR on Day 10 and the morphine dose administered before the switch. Each dot represents one patient (n=54 patients). Spearman rho is correlation coefficient. Solid and dashed lines represent best-fit straight line and 95% confidence intervals, respectively. Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions


Download ppt "Morphine-Methadone Opioid Rotation in Cancer Patients: Analysis of Dose Ratio Predicting Factors  Miguel Angel Benítez-Rosario, MD, PhD, Antonio Salinas-Martín,"

Similar presentations


Ads by Google